title: Regulation of soluble vascular endothelial growth factor receptor (sFlt-1/sVEGFR-1) expression and release in endothelial cells by human follicular fluid and granulosa cells.
abstract: BACKGROUND
  During the female reproductive cycle, follicular development and corpus luteum formation crucially depend on the fast generation of new blood vessels. The importance of granulosa cells and follicular fluid in controlling this angiogenesis is still not completely understood. Vascular endothelial growth factor (VEGF) produced by granulosa cells and secreted into the follicular fluid plays an essential role in this process. On the other hand, soluble VEGF receptor-1 (sFlt-1) produced by endothelial cells acts as a negative modulator for the bioavailability of VEGF. However, the regulation of sFlt-1 production remains to be determined.
  
  
  METHODS
  We analyzed the influence of human follicular fluid obtained from FSH-stimulated women as well as of human granulosa cell conditioned medium on sFlt-1 production in and release from human umbilical vein endothelial cells (HUVEC) in vitro. Soluble Flt-1 gene expression was determined by RT-PCR analysis, amount of sFlt-1-protein was quantified by Sandwich-ELISA.
  
  
  RESULTS
  Human follicular fluid as well as granulosa cell-conditioned medium significantly inhibit the production of sFlt-1 by endothelial cells on a posttranscriptional level. Treatment of cultured granulosa cells with either hCG or FSH had not impact on the production of sFlt-1 inhibiting factors. We further present data suggesting that this as yet unknown sFlt-1 regulating factor secreted by granulosa cells is not heat-sensitive, not steroidal, and it is of low molecular mass (< 1000 Da).
  
  
  CONCLUSIONS
  We provide strong support that follicular fluid and granulosa cells control VEGF availability by down regulation of the soluble antagonist sFlt-1 leading to an increase of free, bioactive VEGF for maximal induction of vessel growth in the ovary.
authors.affiliation: Institute of Anatomy, University Hospital, Essen, Germany. ruth.gruemmer@uni-essen.de
authors.forename: Ruth
authors.initials: R
authors.lastname: Gruemmer
authors.forename: Karin
authors.initials: K
authors.lastname: Motejlek
authors.forename: Daniela
authors.initials: D
authors.lastname: Berghaus
authors.forename: Herbert A
authors.initials: HA
authors.lastname: Weich
authors.forename: Joseph
authors.initials: J
authors.lastname: Neulen
mesh_terms: D000328:Adult; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D017077:Culture Media, Conditioned / Q000494:pharmacology; D015536:Down-Regulation; D042783:Endothelial Cells / Q000378:metabolism / Q000502:physiology*; D005260:Female; D015571:Follicular Fluid / Q000502:physiology*; D005786:Gene Expression Regulation / Q000502:physiology*; D006107:Granulosa Cells / Q000502:physiology*; D006801:Humans; D018919:Neovascularization, Physiologic / Q000502:physiology; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000096:biosynthesis*
chemical_list: D017077:Culture Media, Conditioned; D040281:Vascular Endothelial Growth Factor Receptor-1